SMPDL3b inhibition or C1P supplementation for diabetic kidney disease

DISEASE CATEGORY: Renal

INDICATION: Diabetic nephropathy

Inhibition of SMPDL3b or supplementation with the

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE